La bourse ferme dans 40 min
  • CAC 40

    6 250,77
    -16,51 (-0,26 %)
     
  • Euro Stoxx 50

    4 004,99
    -9,81 (-0,24 %)
     
  • Dow Jones

    33 971,53
    +155,63 (+0,46 %)
     
  • EUR/USD

    1,2055
    +0,0038 (+0,31 %)
     
  • Gold future

    1 773,40
    -8,60 (-0,48 %)
     
  • BTC-EUR

    41 120,39
    -4 633,27 (-10,13 %)
     
  • CMC Crypto 200

    1 136,78
    +12,88 (+1,15 %)
     
  • Pétrole WTI

    62,31
    +0,88 (+1,43 %)
     
  • DAX

    15 250,21
    -70,31 (-0,46 %)
     
  • FTSE 100

    6 928,46
    -9,78 (-0,14 %)
     
  • Nasdaq

    13 942,10
    +123,69 (+0,90 %)
     
  • S&P 500

    4 164,40
    +29,42 (+0,71 %)
     
  • Nikkei 225

    29 020,63
    -167,54 (-0,57 %)
     
  • HANG SENG

    29 078,75
    +323,41 (+1,12 %)
     
  • GBP/USD

    1,3847
    +0,0005 (+0,03 %)
     

Anticonvulsants Market Research Report by Drug types, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

ReportLinker
·5 min de lecture

Anticonvulsants Market Research Report by Drug types (AMPA, Barbiturate, Benzodiazepine, Carbamate Anticonvulsants, and Carbonic Anhydrase Inhibitor), by Application (Anxiety, Bipolar Disorder, Borderline Personality Disorder.

New York, March 12, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Anticonvulsants Market Research Report by Drug types, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06033983/?utm_source=GNW
, Epilepsy, and Fibromyalgia) - Global Forecast to 2025 - Cumulative Impact of COVID-19

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Anticonvulsants Market is expected to grow from USD 9,452.37 Million in 2020 to USD 13,684.43 Million by the end of 2025.
2. The Global Anticonvulsants Market is expected to grow from EUR 8,288.01 Million in 2020 to EUR 11,998.76 Million by the end of 2025.
3. The Global Anticonvulsants Market is expected to grow from GBP 7,368.06 Million in 2020 to GBP 10,666.93 Million by the end of 2025.
4. The Global Anticonvulsants Market is expected to grow from JPY 1,008,807.40 Million in 2020 to JPY 1,460,475.44 Million by the end of 2025.
5. The Global Anticonvulsants Market is expected to grow from AUD 13,726.09 Million in 2020 to AUD 19,871.61 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the Anticonvulsants to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Drug types, the Anticonvulsants Market studied across AMPA, Barbiturate, Benzodiazepine, Carbamate Anticonvulsants, Carbonic Anhydrase Inhibitor, Dibenzazepine, and Triazine.

Based on Application , the Anticonvulsants Market studied across Anxiety, Bipolar Disorder, Borderline Personality Disorder., Epilepsy, Fibromyalgia, Migraine, and Neuropathic Pain.

Based on Geography, the Anticonvulsants Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Anticonvulsants Market including Abbott Laboratories, Astrazeneca PLC, Bausch Health Companies Inc., Biocon Limited, Cadila Pharmaceuticals Limited, Cipla, Inc., Eisai Co., Ltd. by Royalty Pharma, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., GW Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Lundbeck A/S, Mankind Pharma Ltd, Merck KGaA, Novartis AG, Novo Nordisk A/S, Otsuka Pharmaceutical, Pfizer Inc., Sanofi S.A, Sunovion Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., and Wockhardt Limited.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Anticonvulsants Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Anticonvulsants Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Anticonvulsants Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Anticonvulsants Market?
4. What is the competitive strategic window for opportunities in the Global Anticonvulsants Market?
5. What are the technology trends and regulatory frameworks in the Global Anticonvulsants Market?
6. What are the modes and strategic moves considered suitable for entering the Global Anticonvulsants Market?
Read the full report: https://www.reportlinker.com/p06033983/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001